This 30-minute course is a companion to the AACE Acromegaly Diagnostic Approach and Therapeutic Management Options: Improving the Care of Patients course. It is designed to improve your competence and skill in identifying acromegaly to provide appropriate treatment for your patients. Using a variety of case studies, this course provides you the opportunity to apply your knowledge. By incorporating the recommendations made in this activity the practitioner will be able to recommend and deliver treatment accordingly.
Starts 12/17/2020 | Expires 12/16/2022
Acromegaly is a rare, chronic endocrine disorder characterized by the excessive secretion of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). In a recent U.S. study examining healthcare insurance claims, data showed that in the U.S. these rates are higher than rest of world with approximately 3,000 new cases of acromegaly diagnosed per year.
- Identify the early signs, symptoms and comorbidities that indicate a patient should be tested for acromegaly
- Employ clinical practice guidelines for the management of acromegaly and its comorbidities
- Consider the current surgical, medical, and imaging treatment options for acromegaly
Physicians and other allied health professionals involved in the treatment of patients with acromegaly.
Romesh Khardori, MD
ACCME CME Credit
The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Clinical Endocrinologists (AACE) designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit. Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared with the American Board of Internal Medicine (ABIM) through the Accreditation Council for Continuing Medical Education (ACCME) Program and Activity Reporting System (PARS).
Statement of Need
Acromegaly is associated with increased morbidity and mortality; if not properly treated, patients with acromegaly experience a mortality risk 2 to 4 times greater than that of the general population. Cardiovascular (CV) comorbidities associated with acromegaly, are the main contributors to acromegaly-related mortality; additionally, associated respiratory diseases, account for up to 25% of acromegaly-related deaths.
Physicians lack the knowledge and competence to identify the early signs and symptoms of acromegaly, resulting in delayed diagnosis and delayed treatment initiation for patients with this condition. Physicians require improved education on early identification of acromegaly to enable the implementation of clinical practice guidelines. Untreated and even delayed treatment of acromegaly is associated with a broad array of complications.
Despite the availability of effective treatments and the potential of emerging therapies, many patients with acromegaly remain untreated. An international survey, which included responses from physicians practicing in 12 countries including the U.S., showed about one third of survey participants followed treatment guidelines and regularly used recommended measures at 3 months post-surgery to assess treatment outcomes. Thus, while clinical practice guidelines are readily available, physicians who treat patients with acromegaly are in need of education on the implementation of these guidelines into daily clinical practice.
Disclosure/Conflict of Interest
The following physician(s) have nothing to disclose:
- Romesh Khardori, MD
This activity is supported by an independent educational grant from Pfizer, Inc.